Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.56 USD
Change Today +0.001 / 0.18%
Volume 92.8K
CYCC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John Michael Middlecott Banham DL, MA, HonLLD, HonDSc

Non-Executive Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee,Cyclacel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 80 board members in 5 different organizations across 10 different industries.

See Board Relationships
74$76,926

Background*

Sir John Michael Middlecott Banham, DL, MA, Hon LLD, Hon Dsc is a Deputy Lieutenant at Cornwall. Sir Banham served as a Director General of the Confederation of British Industry (CBI), from 1987 to 1992. Sir Banham served as an Honorary Treasurer at the United Kingdom's Cancer Research Campaign prior to its merger with Imperial Cancer Research. Sir Banham serves as the Chairman of Sultan Scientific and Innoveas International Ltd. He serves as the Chairman of Johnson ...

Read Full Background

Corporate Headquarters*

200 Connell Drive
Berkeley Heights, New Jersey 07922

United States

Phone: 908-517-7330
Fax: 866-271-3466

Board Members Memberships*

Chairman
Chairman
Director
2006-Present
Non-Executive Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

Unknown/Other Education
University of Cambridge

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$54,786
Total Calculated Compensation$76,926
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYCC:US $0.56 USD +0.001

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYCLACEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.